Filing Details
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) filed a Form 8-K with the Securities and Exchange Commission on August 14, 2026, disclosing a material event.
8k filedNASDAQ:VTGN
Vistagen Therapeutics, Inc. (VTGN) Reports Material Event to SEC
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) filed a Form 8-K with the Securities and Exchange Commission on August 14, 2026, disclosing a material event.
At publication ·
What changed
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Vistagen Therapeutics (NASDAQ: VTGN) filed a Form 8-K with the SEC on August 14, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $0.27 per share with a market capitalization of $129.3 million.
- The article does not specify the nature of the material event, which could involve leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
Vistagen Therapeutics, Inc.'s stock currently trades at $0.27 with a market capitalization of $129.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Vistagen Therapeutics, Inc.'s stock.
All SEC filings for Vistagen Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View VTGN Stock Page
Frequently Asked Questions
Where can I read VTGN's SEC filings?
Browse all filings on our VTGN SEC filings page.
What types of SEC filings does Vistagen Therapeutics, Inc. file?
Public companies like Vistagen Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.